Report - Tecentriq, INN-atezolizumab - SEFHgruposdetrabajo.sefh.es/genesis/genesis/Documents/... · Web view2.45 AVACS (95%CI, 2.44-2.46) Opción dominada Utilidad calculada (5) -- RATIO DE

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form